2021 annual financial data
Addex Therapeutics 2021 Operating margin
Direct answer
Operating margin was -531.7%.
Operating income was -15,505,917 CHF and net income was -15,351,914 CHF.
Operating cash flow was -14,705,185 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,916,308 CHF
- Operating income
- -15,505,917 CHF
- Net income
- -15,351,914 CHF
- Operating cash flow
- -14,705,185 CHF